Testicular Cancer Survivors Report High Quality of Life

Investigators find quality of life not associated with treatment strategy

WEDNESDAY, Oct. 28 (HealthDay News) -- Long-term survivors of testicular cancer generally report a high quality of life, according to a study published online Oct. 26 in the Journal of Clinical Oncology.

Philip Blach Rossen, M.D., from Aarhus University Hospital in Denmark, and colleagues surveyed 401 Danish long-term survivors of testicular cancer regarding quality of life, depression, fatigue, and health-related symptoms.

The researchers found that quality of life was similar among survivors and the general population. Treatment strategy (chemotherapy, radiotherapy, or surveillance) had little association with quality of life, depression, or fatigue. Patients treated with chemotherapy reported higher levels of peripheral sensory neuropathy, ototoxicity, and Raynaud-like phenomena, which are expected since these adverse effects are known to be widely irreversible, according to the authors.

"Overall, the patients in this study reported high levels of quality of life," Rossen and colleagues conclude. "The results suggest that patients treated for testicular cancer should be informed about the anticipated good post-therapeutic quality of life and the low risk of psychosocial and physical long-term effects."

Full Text (subscription or payment may be required)

Physician's Briefing